Literature DB >> 6166529

The pathology of the Legionella pneumonias. A review of 74 cases and the literature.

W C Winn, R L Myerowitz.   

Abstract

Following the discovery of Legionella pneumophila as the cause of an epidemic of pneumonia at an American Legion convention in Philadelphia, a group of related bacteria were recognized as additional human pathogens. This newly established bacterial genus, Legionella, includes the agents of Legionnaires' disease, Pittsburgh pneumonia, and several related infections. There are many similarities in the pathology of human infection caused by all the Legionella species. All produce a severe confluent lobular or lobar pneumonia, and abscess formation is not uncommon. A leukocytoclastic inflammatory infiltrate of neutrophils and macrophages, "septic" vasculitis of small blood vessels, coagulation necrosis, and focal septal disruption are characteristic but not diagnostic features. The inflammatory response is clearly that of a bacterial pneumonia with a necrotizing component, and does not resemble most mycoplasmal, chlamydial, or viral pneumonias. The bacteria can be demonstrated well by special stains. Acid fastness of Legionella micdadei, the cause of Pittsburgh pneumonia, is a helpful presumptive clue to diagnosis. The bacteria can be presumptively speciated in tissue by direct immunofluorescence. In addition, reliable recovery of the organisms on agar media now allows a specific diagnosis to be made. As a group, these infections are properly referred to as the Legionella pneumonias.

Entities:  

Mesh:

Year:  1981        PMID: 6166529     DOI: 10.1016/s0046-8177(81)80021-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  51 in total

1.  Intracellular growth in Acanthamoeba castellanii affects monocyte entry mechanisms and enhances virulence of Legionella pneumophila.

Authors:  J D Cirillo; S L Cirillo; L Yan; L E Bermudez; S Falkow; L S Tompkins
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 2.  Organising pneumonia.

Authors:  J F Cordier
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

3.  Novel phospholipase A activity secreted by Legionella species.

Authors:  A Flieger; S Gong; M Faigle; M Deeg; P Bartmann; B Neumeister
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

4.  Legionella pneumophila entry gene rtxA is involved in virulence.

Authors:  S L Cirillo; L E Bermudez; S H El-Etr; G E Duhamel; J D Cirillo
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

5.  Legionella pneumophila zinc metalloprotease is structurally and functionally homologous to Pseudomonas aeruginosa elastase.

Authors:  W J Black; F D Quinn; L S Tompkins
Journal:  J Bacteriol       Date:  1990-05       Impact factor: 3.490

6.  Pneumonitis associated with coinfection by human herpesvirus 6 and Legionella in an immunocompetent adult.

Authors:  S K Russler; M A Tapper; K K Knox; A Liepins; D R Carrigan
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

7.  Alveolar macrophages and neutrophils are the primary reservoirs for Legionella pneumophila and mediate cytosolic surveillance of type IV secretion.

Authors:  Alan M Copenhaver; Cierra N Casson; Hieu T Nguyen; Thomas C Fung; Matthew M Duda; Craig R Roy; Sunny Shin
Journal:  Infect Immun       Date:  2014-08-04       Impact factor: 3.441

8.  Growth of Legionella pneumophila in Acanthamoeba castellanii enhances invasion.

Authors:  J D Cirillo; S Falkow; L S Tompkins
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor alpha and nitric oxide.

Authors:  J K Brieland; D G Remick; P T Freeman; M C Hurley; J C Fantone; N C Engleberg
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Interaction of primate alveolar macrophages and Legionella pneumophila.

Authors:  R F Jacobs; R M Locksley; C B Wilson; J E Haas; S J Klebanoff
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.